These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37492136)

  • 41. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.
    Al-Otaiby M; Krissaane I; Al Seraihi A; Alshenaifi J; Qahtani MH; Aljeri T; Zaatari E; Hassanain M; Algwizani A; Albarrag A; Al-Mozaini M; Alabdulaali M
    Int J Infect Dis; 2022 Sep; 122():758-766. PubMed ID: 35840098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.
    Pulliam JRC; van Schalkwyk C; Govender N; von Gottberg A; Cohen C; Groome MJ; Dushoff J; Mlisana K; Moultrie H
    Science; 2022 May; 376(6593):eabn4947. PubMed ID: 35289632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid Increase in Suspected SARS-CoV-2 Reinfections, Clark County, Nevada, USA, December 2021.
    Ruff J; Zhang Y; Kappel M; Rathi S; Watkins K; Zhang L; Lockett C
    Emerg Infect Dis; 2022 Oct; 28(10):1977-1981. PubMed ID: 35969420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation and comparison of the sensitivity of three commercial RT-qPCR kits used for the detection of SARS-CoV-2 in Santiago, Chile.
    Luraschi R; Santibáñez Á; Barrera-Avalos C; Vallejos-Vidal E; Mateluna-Flores C; Alarcón J; Cayunao J; Mella-Torres A; Hernández F; Inostroza-Molina A; Valdés D; Imarai M; Acuña-Castillo C; Reyes-López FE; Sandino AM
    Front Public Health; 2022; 10():1010336. PubMed ID: 36518569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reinfection rate and disease severity of the BA.5 Omicron SARS-CoV-2 lineage compared to previously circulating variants of concern in the Canary Islands (Spain).
    Ciuffreda L; Lorenzo-Salazar JM; García-Martínez de Artola D; Gil-Campesino H; Alcoba-Florez J; Rodríguez-Pérez H; Íñigo-Campos A; Salas-Hernández J; Rodríguez-Nuñez J; Muñoz-Barrera A; Valenzuela-Fernández A; Díez-Gil O; González-Montelongo R; Flores C
    Emerg Microbes Infect; 2023 Dec; 12(1):2202281. PubMed ID: 37039029
    [No Abstract]   [Full Text] [Related]  

  • 47. Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant.
    Shete AM; Patil DY; Sahay RR; Sapkal GN; Deshpande GR; Yadav PD
    Hum Vaccin Immunother; 2022 Nov; 18(6):2127289. PubMed ID: 36170667
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors and mortality of SARS-CoV-2 reinfection during the Omicron era in Taiwan: A nationwide population-based cohort study.
    Chen YH; Lee CY; Cheng HY; Chen CM; Cheuh YN; Lee CL; Kuo HW
    J Microbiol Immunol Infect; 2024 Feb; 57(1):30-37. PubMed ID: 37978019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic evidence of SARS-CoV-2 reinfection in the Republic of Korea.
    Park AK; Rhee JE; Kim IH; Kim HM; Lee H; Kim JA; Lee CY; Lee NJ; Woo S; Lee J; No JS; Rhie GE; Wang SJ; Lee SE; Park YJ; Park G; Kim JY; Gwack J; Yoo CK; Kim EJ
    J Med Virol; 2022 Apr; 94(4):1717-1722. PubMed ID: 34862628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged ≥18 Years - 18 U.S. Jurisdictions, September 2021-December 2022.
    Ma KC; Dorabawila V; León TM; Henry H; Johnson AG; Rosenberg E; Mansfield JA; Midgley CM; Plumb ID; Aiken J; Khanani QA; Auche S; Bayoumi NS; Bennett SA; Bernu C; Chang C; Como-Sabetti KJ; Cueto K; Cunningham S; Eddy M; Falender RA; Fleischauer A; Frank DM; Harrington P; Hoskins M; Howsare A; Ingaiza LM; Islam AS; Jensen SA; Jones JM; Kambach G; Kanishka F; Levin Y; Masarik JF; Meyer SD; Milroy L; Morris KJ; Olmstead J; Olsen NS; Omoike E; Patel K; Pettinger A; Pike MA; Reed IG; Slocum E; Sutton M; Tilakaratne BP; Vest H; Vostok J; Wang JS; Watson-Lewis L; Wienkes HN; Hagen MB; Silk BJ; Scobie HM
    MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(25):683-689. PubMed ID: 37347715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Observed protection against SARS-CoV-2 reinfection following a primary infection: A Danish cohort study among unvaccinated using two years of nationwide PCR-test data.
    Michlmayr D; Hansen CH; Gubbels SM; Valentiner-Branth P; Bager P; Obel N; Drewes B; Møller CH; Møller FT; Legarth R; Mølbak K; Ethelberg S
    Lancet Reg Health Eur; 2022 Sep; 20():100452. PubMed ID: 35791335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiological Characteristics of COVID-19 during Seven Consecutive Epidemiological Waves (2020-2022) in the North Bačka District, Serbia.
    Banjac J; Vuković V; Pustahija T; Bohucki N; Berić DK; Medić S; Petrović V; Ristić M
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate.
    Vial PA; González C; Apablaza M; Vial C; Lavín ME; Araos R; Rubilar P; Icaza G; Florea A; Pérez C; Concha P; Bastías D; Errázuriz MP; Pérez R; Guzmán F; Olea A; Guzmán E; Correa J; Munita JM; Aguilera X
    Epidemics; 2022 Sep; 40():100606. PubMed ID: 35872438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.
    Jeffery-Smith A; Rowland TAJ; Patel M; Whitaker H; Iyanger N; Williams SV; Giddings R; Thompson L; Zavala M; Aiano F; Ellis J; Lackenby A; Höschler K; Brown K; Ramsay ME; Gopal R; Chow JY; Ladhani SN; Zambon M
    Lancet Healthy Longev; 2021 Dec; 2(12):e811-e819. PubMed ID: 34873592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SARS-CoV-2 Reinfection and Severity of the Disease: A Systematic Review and Meta-Analysis.
    Nguyen NN; Nguyen YN; Hoang VT; Million M; Gautret P
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SARS-CoV-2 vaccine breakthrough reinfection in a health-care worker of Iraq: A case report.
    Hasan DA; Maulud SQ; Jalal PJ; Priyanka ; Choudhary OP
    Hum Vaccin Immunother; 2022 Nov; 18(5):2055947. PubMed ID: 35417318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complete Analysis of the Epidemiological Scenario around a SARS-CoV-2 Reinfection: Previous Infection Events and Subsequent Transmission.
    Pérez Lago L; Pérez Latorre L; Herranz M; Tejerina F; Sola-Campoy PJ; Sicilia J; Suárez-González J; Andrés-Zayas C; Chiner-Oms A; Jiménez-Serrano S; García-González N; Comas I; González-Candelas F; Martínez-Laperche C; Catalán P; Muñoz P; García de Viedma D;
    mSphere; 2021 Oct; 6(5):e0059621. PubMed ID: 34494886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies.
    Nevejan L; Cuypers L; Laenen L; Van Loo L; Vermeulen F; Wollants E; Van Hecke I; Desmet S; Lagrou K; Maes P; André E
    Emerg Infect Dis; 2022 Aug; 28(8):1729-1731. PubMed ID: 35738346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.